Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Resche

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Annals of Surgical Oncology|May 13, 2005
The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancerC Rousseau, J M Classe, L Campion, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 5, 2003
Lymphoscintigraphy in the sentinel lymph node technique for breast tumor: value of early and late images for the learning curveC Rousseau, L Campion, C Curtet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2003
Learning curve for the detection of axillary sentinel lymph node in breast cancerJ M Classe, C Curtet, L Campion, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastasesI Resche, J F Chatal, A Pecking, et al.
Nuclear Medicine Communications|December 1, 1994
Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugateA Chetanneau, J Barbet, P Peltier, et al.
Nuclear Medicine and Biology|January 11, 2001
[131I]-TYR3-octreotide: clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumorsJ Baulieu, I Resche, M Bardies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trialF Kraeber-Bodéré, S Bardet, C A Hoefnagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trialA N Serafini, S J Houston, I Resche, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Annals of Surgical Oncology|May 13, 2005
The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancerC Rousseau, J M Classe, L Campion, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 5, 2003
Lymphoscintigraphy in the sentinel lymph node technique for breast tumor: value of early and late images for the learning curveC Rousseau, L Campion, C Curtet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2003
Learning curve for the detection of axillary sentinel lymph node in breast cancerJ M Classe, C Curtet, L Campion, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastasesI Resche, J F Chatal, A Pecking, et al.
Nuclear Medicine Communications|December 1, 1994
Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugateA Chetanneau, J Barbet, P Peltier, et al.
Nuclear Medicine and Biology|January 11, 2001
[131I]-TYR3-octreotide: clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumorsJ Baulieu, I Resche, M Bardies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trialF Kraeber-Bodéré, S Bardet, C A Hoefnagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trialA N Serafini, S J Houston, I Resche, et al.
Pageof 2